The Grey Zone of Plasma Donors in America
Print Friendly, PDF & Email

The country doesn’t have definitive guidelines that allow donors deferred due to certain false positives to be prequalified. The industry benefits from it. The FDA has not conducted a rigorous and serious study on the long-term health effects of selling plasma.

Verified by MonsterInsights